Cancer BiologybioRxivPreprint
Live immunogenic melanoma cells generated by etoposide treatment upregulate B2M and lose tumor-forming potential
Benjamin W. Lyon, Emma Russo, Cheyenne Colbert…·Ganapathy Sriram
This study shows that etoposide-treated B16-Ova melanoma cells upregulate B2M and lose tumor-forming potential while remaining viable and stimulating T-cell activation.
DOI 10.64898/2026.10.18.759921